Global Multiple Myeloma Partnering 2012 to 2018

Publisher Name :
Date: 01-Oct-2018
No. of pages: 150
Inquire Before Buying

"Delivery of this report will take 1-3 days after purchase."

The Multiple Myeloma Partnering 2012-2015 report provides understanding and access to the multiple myeloma partnering deals and agreements entered into by the worlds leading healthcare companies.

Trends in multiple myeloma partnering deals

Top multiple myeloma deals by value

Deals listed by company A-Z, industry sector, stage of development, technology type

The Global Multiple Myeloma Partnering Terms and Agreements since 2012 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies.

- Trends in partnering deals

- Top deals by value

- Deals listed by company A-Z, industry sector, stage of development, technology type

The report provides understanding and access to the partnering deals and agreements entered into by the world's leading healthcare companies.

The report provides an analysis of partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight where press releases do not.

This data driven report contains multiple links to online copies of actual deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners, where available. Contract documents provide the answers to numerous questions about a prospective partner's flexibility on a wide range of important issues, many of which will have a significant impact on each party's ability to derive value from the deal.

The initial chapters of this report provide an orientation of partnering trends.

Chapter 1 provides an overview of the trends in partnering since 2012, including a summary of deals by industry sector, stage of development, deal type, and technology type.

Chapter 2 provides a review of the top 10 most active companies in the therapy area, including a comprehensive listing of the deals announced by each company.

Chapter 3 provides a comprehensive directory of partnering deals signed and announced since 2012. The chapter is organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc), and technology type. Each deal title links via Weblink to an online version of the deal record, and where available the contract document, providing easy access to each contract document on demand.

Chapter 4 provides a listing of partnering deals where a contract document is available alongside the deal record.

Chapters 5 and 6 provide a summary of M&A deals since 2012 where the acquired company is active in the therapy area of interest.

Chapters 7 and 8 provide a summary of financings since 2012 where the financed company is active in the therapy area of interest.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of technologies and products in the therapy area.

Benefits

Global Multiple Myeloma Partnering Terms and Agreements since 2012 report provides the reader with the following key benefits:

- In-depth understanding of deal trends since 2012

- Access to headline, upfront, milestone and royalty data

- Comprehensive access to multiple deals entered into by the world's biopharma companies since 2012

- Insight into key deal terms included in contracts, where disclosed

- Understand the key deal terms companies have agreed in deals

- Undertake due diligence to assess suitability of your proposed deal terms for partner companies

Global Multiple Myeloma Partnering 2012 to 2018

Table of Contents

Executive Summary

Chapter 1 - Therapypartnering trends in numbers
Partnering in numbers - by year
Partnering in numbers - most active
Partnering in numbers - by industry sector
Partnering in numbers - by deal type
Partnering in numbers - by technology type
Partnering in numbers - by stage of development

Chapter 2 - Most active dealmakers

Chapter 3 - Partnering deals directory
Partnering deals directory - by company A-Z
Partnering deals directory - by deal value
Partnering deals directory - by industry sector
Partnering deals directory - by deal type
Partnering deals directory - by stage of development
Partnering deals directory - by technology area

Chapter 4 - Partnering deals with a contract document
About Wildwood Ventures
Current Partnering
Current Agreements
Recent titles from CurrentPartnering

LIST OF TABLES AND FIGURES

Figure 1: Partnering frequency by year
Figure 2: Partnering most active
Figure 3: Partnering by industry sector
Figure 4: Partnering by deal type
Figure 5: Partnering by technology area
Figure 6: Partnering by stage of development
  • Global and Chinese Castration-Resistant Prostate Cancer (CRPC) /HRPCA Therapeutics Industry, 2018 Market Research Report
    Published: 10-Dec-2018        Price: US 3000 Onwards        Pages: 149
    The 'Global and Chinese Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics industry with a focus on the Chinese market. The report provides key statistics on the market status of the Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics manufacturers and is a valuable source of guidance and directio......
  • Global and Chinese Non-small Cell Lung Cancer Therapeutics Industry, 2018 Market Research Report
    Published: 08-Dec-2018        Price: US 3000 Onwards        Pages: 137
    The 'Global and Chinese Non-small Cell Lung Cancer Therapeutics Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Non-small Cell Lung Cancer Therapeutics industry with a focus on the Chinese market. The report provides key statistics on the market status of the Non-small Cell Lung Cancer Therapeutics manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, ......
  • Global Gene Therapy for Ovarian Cancer Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
    Published: 06-Dec-2018        Price: US 3480 Onwards        Pages: 117
    Ovarian cancer occurs and arises from several types of cells within the ovary, and it has the lowest survival rate of all gynecological cancers. Among many types, epithelial ovarian cancer (EOC) is the most common ovarian cancer, whereas ovarian low malignant potential tumor (OLMPT), germ cell tumor, and stromal ovarian tumor are some of the less common types. It is the seventh most common cancer in women globally and 18th most common cancer overall. The ovarian cancer immunotherapies market has......
  • Global Acute Myeloid Leukemia Therapeutics Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
    Published: 06-Dec-2018        Price: US 3480 Onwards        Pages: 132
    Acute myeloid leukemia is the second frequent type (after acute lymphocytic leukemia) of leukemia diagnosed in infants. About 15% of children from birth to 19 years of age diagnosed with leukemia have acute myeloid leukemia. The risk of acute myeloid leukemia is closely associated with age. About 90% of acute myeloid leukemia is diagnosed in middle age. Incidence rate of acute myeloid leukemia is high in men and women over 50 years. Scope of the Report: This report studies ......
  • Global Small Molecule Targeted Cancer Therapy Market Size, Status and Forecast 2018-2025
    Published: 29-Nov-2018        Price: US 3900 Onwards        Pages: 94
    This report focuses on the global Small Molecule Targeted Cancer Therapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Small Molecule Targeted Cancer Therapy development in United States, Europe and China. In 2017, the global Small Molecule Targeted Cancer Therapy market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2018-2025. The key players c......
  • Global and Chinese Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Industry, 2018 Market Research Report
    Published: 28-Nov-2018        Price: US 3000 Onwards        Pages: 147
    The 'Global and Chinese Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) industry with a focus on the Chinese market. The report provides key statistics on the market status of the Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) manufacturers and is a valuable source of guidance and direction for com......
  • Global Non-small Cell Lung Cancer Therapeutics Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
    Published: 27-Nov-2018        Price: US 3480 Onwards        Pages: 119
    Lung cancer is one of the most common malignant tumors in the world and has become the number one cause of death in malignant tumors in urban population in China. Non-small cell lung cancer accounts for about 80% of all lung cancers, and about 75% of patients are already in the advanced stage, and the 5-year survival rate is very low. Scope of the Report: This report studies the Non-small Cell Lung Cancer Therapeutics market status and outlook of Global and major regions, f......
  • Global Actinic Keratosis Treatment Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 21-Nov-2018        Price: US 3480 Onwards        Pages: 121
    Actinic keratosis (AK) is a form of skin cancer and it is also known as solar keratosis. This indication tends to affect the sun-exposed parts of the skin such as face, bald scalp, lips, and the back of the hands among others. As a result of the exposure, the skin tends to become rough, uneven and display a warty look. Scope of the Report: The worldwide market for Actinic Keratosis Treatment is expected to grow at a CAGR of roughly xx% over the next five years, will reach ......
  • Global Immuno-Oncology Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
    Published: 15-Nov-2018        Price: US 3480 Onwards        Pages: 137
    Immuno-Oncology (I-O) is an innovative area of research that seeks to help the body's own immune system fight cancer. The goal is to address the unmet need for long-term survival in patients with advanced cancers. Scope of the Report: The global Immuno-Oncology market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023. The Asia-Pacific will occupy for more market share in foll......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs